Warning letter
Cargill Incorporated: warning letter of Jan 27, 2020
FDA warning letter 589386 · Division of Human and Animal Food Operations East III
Key facts
| Reference number | 589386 |
|---|---|
| Company | Cargill Incorporated |
| Subject | CGMP/Medicated Feeds/Adulterated |
| Issue date | Jan 27, 2020 |
| Posted date | Mar 31, 2020 |
| Issuing office | Division of Human and Animal Food Operations East III |
| Product type | Veterinary |
| CFR sections cited | 225, 507, 225.1(b)(1), 225.58(d), 507.1(a)(1)(ii), 510.301(a)(2), 507.33(c)(1), 507.42(b), 507.50(b)(3), 507.50(c), 558.4 |
| Inspection city | Cleveland |
| Inspection ZIP | 27013 |
| Inspection start date | Jun 4, 2019 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: